We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LNDZF market cap is 15.67M. The company's latest EPS is CAD -0.1991 and P/E is -1.10.
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 613k | 50k | 18.12M | 33.6M | 62.63M |
| Operating Income | -1.08M | -526k | -802k | -2.65M | -15.88M |
| Net Income | -2.34M | -2.67M | -4.37M | -15.9M | -15.6M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 9.33M | 13.13M | 42.68M | 52.05M | 48.26M |
| Total Liabilities | 366k | 6.49M | 29.53M | 36.72M | 44.25M |
| Total Equity | 8.97M | 6.64M | 13.15M | 15.33M | 4M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -128k | -975k | -3.7M | -219k | -919k |
| Investing | -900k | 76k | -4.62M | -5.6M | -1.52M |
| Financing | N/A | 5.43M | 3.94M | -220k | 825k |
| Market Cap | 15.67M |
| Price to Earnings Ratio | -1.10 |
| Price to Sales Ratio | 0.28 |
| Price to Cash Ratio | 18.8 |
| Price to Book Ratio | 4.31 |
| Dividend Yield | - |
| Shares Outstanding | 78.37M |
| Average Volume (1 week) | 12.63k |
| Average Volume (1 Month) | 10.2k |
| 52 Week Change | -19.03% |
| 52 Week High | 0.315 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0.2 (99.4%) |
| Company Name | Evome Medical Technologies Inc (PK) |
| Address |
suite 200e - 1515a bayview avenue east yorkshire M4G 3B5 |
| Website | https://www.salonaglobal.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
